A Phase 2b, Randomized, Double-Blind, Placebo-Controlled

Project: Research project

Project Details

Description

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hematopoietic Cell Transplant (HCT)
StatusFinished
Effective start/end date6/10/1412/31/17

Funding

  • Gilead Sciences, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.